IBYME 02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Neutralizing soluble tumor necrosis factor alpha overcomes trastuzumab-resistant breast cancer immune evasion by downregulating mucin 4, improving NK cell function and decreasing myeloid-derived suppressor cells in tumor microenvironment
Autor/es:
BRUNI S; INURRIGARRO G; ELIZALDE PV; DE MARTINO M; FRAHM I; SCHILLACI R; MERCOGLIANO MF; CHERVO MF, IZZO F, DE MARTINO M, VENTURUTTI L, MADERA S, GOMEZ POVIÑA JC, CHIAUZZI VA, PROIETTI CJ, GUZMÁN P, ROA JC, CHARREAU EH, SCHILLACI R, ELIZALDE PV, CORDO RUSSO RI.
Reunión:
Simposio; San Antonio Cancer Research Simposium; 2018
Resumen:
Neutralizing soluble tumornecrosis factor alpha overcomes trastuzumab-resistant breast cancer immuneevasion by downregulating mucin 4, improving NK cell function and decreasingmyeloid-derived suppressor cells in tumor microenvironment. San Antonio Breast Cancer Simposuim [P06-20-14], 4-8 deDiciembre de 2018, San Antonio, USA. Cancer Research 78, issue 4, supplement,Feb 2019.
